JANUARY - FEBRUARY 2025LIFE SCIENCES REVIEW1LIFESCIENCESREVIEW.COMEUROPE SPECIALISSN 2831-8331REVOLUTIONISING CANCER IMMUNOTHERAPY BY REAWAKENING THE IMMUNE SYSTEMIMMUNOCINEMatthew Halpert,Founder and CEO CANCERIMMUNOTHERAPIESCOMPANY OFTHE YEARIN EUROPE2025JANUARY - FEBRUARY 2025
Page 2 >